TH
TEVA icon

Timber Hill’s Teva Pharmaceuticals TEVA Stock Holding History

Timber Hill’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-16,562
Closed -$513K – 1740
2017
Q1 		$531K Sell
16,562
-919
-5% -$31.4K ﹤0.01% 1450
2016
Q4 		$634K Sell
17,481
-83,022
-83% -$3.31M ﹤0.01% 1527
2016
Q3 		$4.62M Buy
100,503
+82,772
+467% +$4.32M 0.02% 509
2016
Q2 		$891K Sell
17,731
-77,447
-81% -$4.12M ﹤0.01% 1295
2016
Q1 		$5.09M Buy
95,178
+53,660
+129% +$3.15M 0.02% 511
2015
Q4 		$2.73M Buy
41,518
+34,464
+489% +$2.13M 0.01% 821
2015
Q3 		$398K Sell
7,054
-48,351
-87% -$3.14M ﹤0.01% 1906
2015
Q2 		$3.27M Sell
55,405
-2,748
-5% -$170K 0.01% 799
2015
Q1 		$3.62M Buy
+58,153
New +$3.38M 0.02% 740
2014
Q4 		– Sell
-34,399
Closed -$1.92M – 2724
2014
Q3 		$1.85M Buy
34,399
+931
+3% +$49.3K 0.01% 1178
2014
Q2 		$1.75M Sell
33,468
-33,717
-50% -$1.72M 0.01% 1261
2014
Q1 		$3.55M Sell
67,185
-30,704
-31% -$1.42M 0.02% 815
2013
Q4 		$3.92M Sell
97,889
-37,213
-28% -$1.47M 0.01% 914
2013
Q3 		$5.1M Buy
135,102
+49,298
+57% +$1.92M 0.02% 834
2013
Q2 		$3.36M Buy
+85,804
New +$3.34M 0.01% 1066

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Timber Hill's TEVA Position: Q2 2017 in Review

Timber Hill sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 16,562 shares — an estimated $513K sold.

Timber Hill first reported a position in TEVA in Q2 2013 and held it in 15 quarters. The position peaked at $5.1M in Q3 2013. 650 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Timber Hill reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 16,562 Teva Pharmaceuticals shares in Q2 2017, an estimated $513K.
  • Timber Hill first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Timber Hill's Teva Pharmaceuticals position peaked at $5.1M in Q3 2013.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.